This study investigated the effects of 8 weeks of Galileo Therapy on different disease related scores (PDDS, MSCF) in MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show not only improvements in PDDS and PSAT-3 by up to 18% but also an increase in HSFC (MS Functional Composite: walking distance, hand function, calculation test) in average by 0.36SD…